Foster AE, Dotti G, Lu A, Andreeff M , Goodell M, Rooney CM, Brenner MK
It is typically handled under coldchain conditions to maintain stability
The GLP-1 meal replacement market is segmented by Product Type (Ready-to-drink Shakes, Powder Meal Replacements, High-protein Nutrition Drinks, Soup and Savory Meal Replacements, Bar-based Meal Replacements), Nutritional Focus (High Protein, High Fiber, Low Sugar, Digestive Support, Micronutrient-fortified, Satiety-support Formulations), Consumer Stage (Active GLP-1 Users, Weight-maintenance Users, GLP-1 Step-down Users, General Weight-management Consumers), Distribution Channel (Pharmacies and Health Stores, Supermarkets and Hypermarkets, Direct-to-Consumer, E-commerce Marketplaces, Clinical and Wellness Channels), Pack Format (Single-serve Bottles, Sachets, Multi-serve Tubs, Ready Packs, Variety Packs), End Use (Breakfast Replacement, Lunch Replacement, Structured Weight-management Programs, Recovery Nutrition, On-the-go Consumption), and Region
When these compounds were tested in INS-1 832/3 beta cells 21 with a prolonged incubation to mimic in vivo drug exposure, we found that compounds exhibiting higher internalization also had reduced maximal insulin release (Fig
Degenerative neurologic disease in patients formerly treated with human growth hormone
It further states that any form of advertisement, whether direct or indirect, which promotes prescription-only medicines to the general public, exaggerates therapeutic efficacy, suggests assured or guaranteed weight-loss outcomes, downplays lifestyle modification measures such as diet, exercise and behavioural interventions or induces demand for pharmacological therapy may constitute as misleading promotion of prescription drugs and could invite regulatory action under the Drugs Rules, 1945
